Gatifloxacin
CAS No. 112811-59-3
Gatifloxacin ( AM 1155;BMS 206584-01;PD 135432;AM1155;BMS206584-01 )
Catalog No. M10449 CAS No. 112811-59-3
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 37 | In Stock |
|
1G | 43 | In Stock |
|
Biological Information
-
Product NameGatifloxacin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
-
DescriptionA fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV; displays 2- to 16-fold more active than ciprofloxacin and ofloxacin against Staphylococcus aureus with MICs of 0.1-0.78 ug/mL.
-
SynonymsAM 1155;BMS 206584-01;PD 135432;AM1155;BMS206584-01
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorTopoIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number112811-59-3
-
Formula Weight375.39
-
Molecular FormulaC19H22FN3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
-
Chemical Name3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hosaka M, et al. Antimicrob Agents Chemother. 1992 Oct;36(10):2108-17.
2. Tomioka H, et al. Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63.
3. Wakabayashi E, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):594-601.
2. Tomioka H, et al. Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63.
3. Wakabayashi E, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):594-601.
molnova catalog
related products
-
Sulbenicillin Sodium
Sulbenicillin Sodium is is a penicillin antibioticis a Penicillin antibiotic with antibacterial activity.
-
Linaroside
Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
-
PBP 10
Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.